The TMS machine used at Butler Hospital was determined by the FDA to provide safe and well-tolerated treatment. The data collected in clinical trials with this device resulted in FDA clearance “for the treatment of Major Depressive Disorder in adult patients who have failed to achieve satisfactory improvement from one prior antidepressant medication at or above the minimal effective dose and duration in the current episode.
In an “open label” trial, which is most like a real world clinical practice, approximately 1 out of 2 patients treated with the TMS Therapy device used at Butler Hospital experienced significant improvement in depression symptoms. TMS-treated patients also experienced significant improvement in anxiety, appetite changes, aches and pains, and lack of energy associated with depression.
Approximately 1 out of 3 patients treated with TMS Therapy experienced complete symptom relief at the end of six weeks.
Back to Transcranial Magnetic Stimulation (TMS)